VFV

N/A

Report date: 2025/01/26 17:46:44
NME

Base Information

Drug NameVFV
Drug Alias NameCYP51 inhibitor (Vanderbilt University)VFV
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsNeoplasmsChagas DiseaseLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University
Inactive CompaniesN/A
Active IndicationsNeoplasmsChagas DiseaseLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A